Literature DB >> 15193485

Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.

Peter Conner1, Gunilla Svane, Edward Azavedo, Gunnar Söderqvist, Kjell Carlström, Thomas Gräser, Friedrich Walter, Bo von Schoultz.   

Abstract

OBJECTIVE: To study the effect on mammographic breast density of two different continuous combined regimens for hormone therapy.
DESIGN: Randomized clinical study.
SETTING: University hospital. PATIENT(S): Postmenopausal women without any previous history of breast disorder. INTERVENTION(S): The women received either estradiol valerate/dienogest or estradiol/norethisterone acetate. Mammograms and venous blood samples were obtained at baseline and after 6 months. MAIN OUTCOME MEASURE(S): Change in mammographic breast density. Correlations with levels of hormones, growth factors, and binding proteins. RESULT(S): An increase in mammographic density was recorded in approximately 50% of the women, and there were no differences between treatments. Increased density showed a positive correlation with estradiol, estrone, and sex hormone-binding globulin and showed a negative association to free T. Among hormonal factors, levels of free T were the most important for predicting increased density. CONCLUSION(S): Continuous combined hormone therapy with different progestogens has a marked impact on the breast.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193485     DOI: 10.1016/j.fertnstert.2004.02.096

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Physical activity and mammographic breast density: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz; Kathleen Wolin
Journal:  Breast Cancer Res Treat       Date:  2012-07-20       Impact factor: 4.872

2.  Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer.

Authors:  Lusine Yaghjyan; Graham A Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2012-03-23       Impact factor: 2.506

3.  Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors.

Authors:  Lusine Yaghjyan; Graham A Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.872

4.  Interactions of alcohol and postmenopausal hormone use in regards to mammographic breast density.

Authors:  Lusine Yaghjyan; Graham Colditz; Heather Eliassen; Bernard Rosner; Aleksandra Gasparova; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2018-06-25       Impact factor: 2.506

5.  Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort.

Authors:  L Yaghjyan; M C Mahoney; P Succop; R Wones; J Buckholz; S M Pinney
Journal:  Br J Cancer       Date:  2012-01-26       Impact factor: 7.640

6.  Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study.

Authors:  Carolyn Crandall; Shana Palla; Beth A Reboussin; Giske Ursin; Gail A Greendale
Journal:  Breast Cancer Res       Date:  2005-09-22       Impact factor: 6.466

Review 7.  Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs).

Authors:  Kristof Chwalisz; Ramesh Garg; Robert Brenner; Ov Slayden; Craig Winkel; Walter Elger
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.